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INTRODUCTION
In the vast majority of tropical and sub-tropical
regions of the world, malaria remains the most complex
and overwhelming health problem, facing humanity
with 300 to 500 million cases and 2 to 3 million deaths
per year (1). About 90% of all malaria deaths in the
world today occur in Africa south of the Sahara because
the majority of infections in the region are caused by
Plasmodium falciparum, the most dangerous of the four
human malaria parasites and also because the most
effective malaria vector - the mosquito Anopheles
gambiae - is the most widespread and the most difficult
to control (2). Most people at risk of the disease in sub-
Saharan Africa live in areas where vector transmission
of malaria is common and occurs with sufficient
frequency that other potential routes of transmission
such as induced malaria, congenital malaria and malaria
via needle stick injury are often neglected (1). 
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ABSTRACT:  Induced malaria by blood transfusion is a potential health hazard but is often neglected
in many malaria endemic areas. Standard parasitological technique was used to determine the
prevalence of malaria among blood donors in the South-eastern Nigeria. Of the total 325 blood donors
(310 males and 15 females) screened, 133 (40.9%, CI 95%: 35.6-46.2%) were infected with malaria
parasite, 78 (58.6%) had 1-10 parasites per 100 thick film fields ('+' or 4-40 parasites per mm3) while
55 (41.4%) had 11-100 parasites per 100 thick film fields ('++' or 41-400 parasites per mm3). P.
falciparum was identified in all the infected cases, however 3 (2.3%) persons had mixed infection with
P. malariae. Males were more infected (41.3%, CI 95%: 35.8-46.8%) than females (33.3%, CI 95%: 9.4-
57.2%). The infection decreased with age with highest prevalence of 48.5% among those aged 20-25
years. The infection significantly varied with age but not with sex (P<0.05). Individuals with blood
group B were slightly more infected (42.1%, 95%CI., 19.6-64.6%) than those of groups O (41.0%,CI
95%: 35.3-46.7%)  and A (40.0%, CI 95%: 20.8-59.2%) but there was no significant difference (P <
0.05). Highest prevalence of infection was recorded in the month of April corresponding to the onset of
the wet season. An overhaul of existing blood donation policies in many health facilities in the sub-
Saharan Africa to incorporate malaria screening is advocated. Curative antimalarial drugs followed by
prophylactic drugs should be given to all recipients of Parasitized blood.
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Induced malaria by blood transfusion was first
reported in 1911 (3), and it is well established that all
four human malaria parasites (P. falciparum, P. vivax, P.
ovale and P. malariae) may be transfusion-transmitted
(4). Blood is mainly used in the management of
emergencies involving patients with life-threatening
anaemia accompanied by respiratory distress, most
frequently caused by severe malaria and or
malnutrition. Although this process is a life-saving
venture, it also poses problems if not well managed, as
there are always a risk of immunological adverse
reactions and transmission of other blood-borne
pathogens (5). The transmission of malaria by blood
transfusion is a serious risk, as the diagnosis of malaria
in the recipient is unexpected and this is often missed
(6). Hence, infected blood donors are considered a
potential hazard for blood recipients.
The fact that malarial parasites can survive in red
blood cells at refrigerator temperatures (2-6oC) for days
or weeks lead to the original exclusion of all blood
donors who could represent a potential risk (7).
Regulations on blood transfusion criteria to this effect
are already operational in affluent parts of the world
such as Canada (8), the USA (9), and Switzerland (10),
where malaria has long been eradicated. In most parts of
sub-Saharan Africa, where the malaria scourge is still
very severe, such regulations are essentially lacking,
largely because of the dearth of scientific information
on the risk of transfusion-transmitted malaria in many
areas of intense or stable malaria transmission, that is,
where malaria transmission occurs throughout the year
by long-lived, anthropophilic vector anopheline
mosquitoes (6, 11)
In Nigeria, as in other tropical developing countries,
the high level of occurrence of blood-demanding health
conditions due to the increase in road accidents,
pregnancy-related haemorrhage, armed robbery attacks,
and violent events, amplify the possibility of the
transmission of blood-borne diseases. The long-
standing concern about transfusion-transmitted hepatitis
and human immunodeficiency virus (HIV) infection has
overshadowed the fact that other diseases, particularly
malaria, spread by transfusion of blood components
(12). Because post-transfusional malaria may not only
compound the already deplorable health condition of
recipients but may also be fatal, the need for effective
donor selection guidelines cannot be overstated. The
present study was therefore undertaken to assess the
prevalence of malaria parasites among blood donors, in
order to highlight the potential risk associated with
induced malaria by blood transfusion in south-eastern
Nigeria, an area of stable malaria transmission. This is
with the view to providing scientific information
required for the formulation of effective blood-donation
policy in resource-constrained settings of the tropics.
Although rare, malaria is probably the most
commonly recognized parasitic complication of
transfusion (13). Malarial parasites survive for at least a
week in components stored at room temperature or at
4oC (14). Asymptomatic carriers are generally the
source of transfusion-transmitted malaria. Since healthy
blood donors are selected for blood donation, density of
parasites is usually very low, if present and hence may
be missed (13). In sub-Saharan Africa where malaria is
hyper-endemic, this can pose a serious health hazard to
blood recipients. For instance, in the United States, the
incidence of transfusion malaria is about 1: 4,000,000
(14). The risk of transmitting viral infections such as
HIV and hepatitis as well as bacteria by blood
transfusion is reportedly higher compared to malaria.
The risk of HBV transmission by blood transfusion in
the United States was estimated by the Retrovirus
Epidemiology Donor Study (REDS) as 1:63,000 units
transfused (15). The risk of transmission of HIV and
HCV in Canada through blood transfusion was
estimated to be 1 in 752,000 and 1 in 225,000 donations
respectively (16). Transfusion transmitted bacterial
reaction resulting from bacterial contamination of blood
components is the most common infectious adverse
event. Approximately 1 in 2,000-3,300 units of platelets
and 1 in 38,500 units of red cells are contaminated with
bacteria; however, not every contaminated component
causes reactions. The incidence of transfusion
transmitted bacterial reaction is estimated to range from
1 in 500,000 units of red cells to 1 in 50,000 units of
platelets (17). The public health importance of




This study was hospital-based and conducted at the
Federal Medical Centre (FMC) and Ebonyi State
University Teaching Hospital (EBSUTH); the two
largest health institutions located in Abakaliki, the
capital city of Ebonyi State, south-eastern Nigeria. The
choice of the two hospitals was because they both serve
as referral centres for blood transfusion services in the
south-eastern Nigeria. The study area is defined by
longitude 8o61611E and latitude 6o2212811N, elevated
at 380ft above sea level and covers an area of
approximately 51 km2.  The vegetation characteristic is
that of the tropical rain forest with an average annual
rainfall of about 1600mm and an atmospheric
temperature of 30oC. There are two distinct seasons, the
wet and the dry seasons, the former taking place
between April and October, while the latter occurs from10 McGill Journal of Medicine 2006
November to March. Malaria transmission in the area is
perennial.
Ethical Consideration
The approval for this study was obtained from the
Faculty of Clinical Medicine (Infectious Disease
Research), College of Health Sciences, Ebonyi State
University Abakaliki. Approval was also obtained from
Ethical/Medical Advisory Committee of the two
hospitals (EBSUTH and FMC). The approval was on
the agreement that patient anonymity must be
maintained, good laboratory practice/quality control
ensured, and that every finding would be treated with
utmost confidentiality and for the purpose of this
research only. 
Study Population/ Sampling Techniques
A total of 325 apparently healthy individuals who
visited the FMC and EBSUTH for blood donation from
February to June 2005 were considered for the study.
Subjects were made up of 310 males and 15 females,
aged 20-40 years old.  Before inclusion into the study
population, each donor's HIV-serostatus was
determined. This was the number one pre-requisite for
blood donation at the hospitals. Hence the 325
individuals enrolled were HIV-negative. The donors
included commercial blood donors who offer a unit of
blood for a fee paid by the contracted hospital vendor,
replacement blood donors who were family members or
relations of recipients of blood, and volunteer blood
donors who were well-meaning members of the society
who offered themselves for free, non-directed blood
donation. All donors were verbally notified prior to
sample collection and their informed consent was duly
obtained. About 2ml of blood sample was obtained by
venepuncture from each patient for malaria parasite
screening. For the purpose of the research, no personal
identifiers (names, ID number, address, etc) were used
on the blood sample of the participants. Instead, bar-
coded numbers were used to ensure anonymity of the
donors, to facilitate laboratory procedures and minimise
the chances of errors during the handling of the blood
specimens. The sex of each patient was recorded while
their age was obtained by interview. In Nigeria, blood
donation is an activity that is almost exclusively
restricted to males. This explains why we had few
females compared to males in the study population.
Laboratory Analysis
Giemsa-stained thick and thin blood films were
performed within an hour of collection to identify
individuals infected with the malaria parasite as
previously described (5). Parasite count was determined
using the Plus System (18).The ABO blood grouping
test was performed for all subjects using the slide
method as outlined previously (19), with commercially
available reagents which produced strong agglutination
within 1-2 minutes (Murex Diagnostics, Inc. Dartford,
UK).
Statistical Analysis
Differences in proportion were evaluated using the chi-
square test. Statistical significance was achieved if P <
0.05.
RESULTS
Of the total 325 blood donors (310 males and 15
females) screened, 133 (40.9%, CI 95%: 35.6-46.2%)
were infected with malaria parasites. Of the infected
individuals, 78 (58.6%) had 1-10 parasites per 100 thick
film fields ('+' or 4-40 parasites per mm3), while 55
(41.4%) had 11-100 parasites per 100 thick film fields
('++' or 41-400 parasites per mm3). P. falciparum was
identified in all the infected cases, however mixed
infection with P. malariae was identified in 3 (2.3%) of
those infected.  Results showed that 128 (41.3%, CI
95%: 35.8-46.8%) of the males and 5 (33.3%, CI 95%:
9.4-57.2%) of the females had the malaria parasite. The
infection decreased with age among the donors, with
individuals aged 20-25 years old recording the highest
prevalence of 48.5%. No infection was observed among
those 36-40 years old (Table 1). Statistical analysis
indicated a significant difference in age (χ2calculated =
16.80, χ2 tabulated = 7.81, df = 3, P<0.05), but none in
the sex (χ2 calculated = 0..36, χ2 tabulated = 3.84, df
=1, P<0.05).
With the exception of blood group AB, all other blood
types were observed. Blood group AB was not recorded
because donors with this blood group are often very rare
in the study area. Blood group O was the dominant
blood type (86.5%). Of the 281, 25 and 19 individuals
that were examined in blood group O, A and B
respectively, 115 (41.0%, CI 95%: 35.3-46.7%) of
group O individuals, 10 (40.0%, 95%CI., 20.8-59.2%)
of group A, and 8 (42.1%,  CI 95%: 19.6-64.6%) of
group B, were infected with the malaria parasite (Table
2). The Chi-square test indicated no significant
difference in the trend (χ2 calculated=0.02, χ2 tabulated
= 5.99, df = 2, P<0.05).
The infection was also recorded according to the
various months of the study where a total of 35, 52, 105,
98 and 35 blood samples were examined for the months
of February, March, April, May, and June respectively.
Their respective prevalence rates were 37.1% (n=13),
40.4% (n=21), 42-9%) (n=45), 40.8% (n=40) and
40.9% (n = 14) (Table 2). Statistically, no significant
difference was observed (χ2calculated=0.38, χ2
tabulated = 9.49, df = 4, P<0.05).Malaria 11 Vol. 9 No. 1
DISCUSSION
The safety of donor-blood for transfusion has been a
major concern to health workers. The high prevalence
of malaria (40.9%) as observed among blood donors in
this study strongly suggests a serious risk of
transfusion-transmitted malaria in the south-eastern
Nigeria. Similar studies conducted in other parts of
Nigeria indicated malaria prevalence ranging from
30.2%-40.0% among blood donors (11, 20). A number
of reports from other areas of stable malaria
transmission in sub-Saharan Africa also consistently
indicated relatively high prevalence (above 33%) of the
malaria parasite in transfused blood (6, 21). Transfusion
malaria was described as particularly common in
countries where blood donation has become a
commercial transaction and where the blood donors
come from less affluent social classes (22). This trend
has become a dominant feature in the sub-Saharan
Africa including Nigeria, where a majority of the blood
donation comes from commercial donors, most of
whom are low-income earners and live in places where
vector transmission of malaria is high (23). This may
have accounted for the high prevalence of infection
observed in this present study.
Findings from this study indicated a higher
percentage of infection among male compared to
female blood donors (41.3% vs 33.3%), although no
significant difference was observed statistically. In a
study conducted in Columbia, males were found to be
more infected with malaria parasites than females (59%
vs 41%) (24), however, in the Caribbean and Ghana
reports, more females were infected (25). 
Interestingly, the prevalence of malaria in this study
decreased with age, and individuals aged 20-25 years
were most infected. The reason for this outcome was
not apparently clear even though a statistically
significant difference was obtained. It is however
established that in malaria endemic areas of sub-
Saharan Africa, the younger members of the community
are more disposed to the infection than older individuals
(2), probably due to their greater involvement into
nocturnal activities that enhance contact with
mosquitoes, which may be social or occupational in
nature. In addition, the use of insecticide treated bed
nets is a very rare occurrence among young men in their
early 20s in south-eastern Nigeria and this trend may
have influenced the prevalence of infection. The
importance of intensifying malaria control efforts
among adolescents/young adults cannot be overstated.
This is because of the enormous public health
implication of age-related prevalence of malaria, in
which case these individuals not only constitute the
most infected population (48.5%), but also the
dominant blood donor population (62.8%), as
evidenced from this study. 
When malaria infection was associated with ABO
blood group, it was observed that individuals with blood
group B were slightly more likely to be infected than
those of groups O and A, although Chi-square test
indicated no significant difference between them. A
number of studies have shown that susceptibility to
several infectious diseases is related to the patient's
blood group (26,27). Although the relationship between
blood group and susceptibility to malaria has been
studied by several researchers, these studies have been
unable to link ABO blood groups to the incidence of
malaria parasitemia, and  results have been
contradictory (26,27,28). However, in a study
comparing distribution of blood groups in malaria
patients conducted in India in the early 1980s, it was
reported that group B showed the highest susceptibility
(41.8%) amongst the infected cases, followed by group
A (29%), group O (22.2%) and group AB (7%) (29).
Recent studies of the pathogenesis of malaria have
shown that some strains of Plasmodium falciparum
preferentially trigger rosette formation depending on
the red blood cell blood group, with A and B group cells
being more likely to form rosettes, and the individuals
with these groups to be at greater risk of developing
severe central nervous system malaria (30,31). Since no
significant difference was obtained among the blood
groups in this study, the results suggest that malaria
occurs in individuals of any blood group, and no
particular blood group precludes the susceptibility to
malaria. A similar conclusion was also arrived at in
Zimbabwe (32).
There was no significant variation of the infection
with respect to the months (season) (P < 0.05), although
the highest prevalence was recorded in the month of
April corresponding to the onset of the wet season, a
period when the transmission of malaria is usually at the
peak in the south-eastern Nigeria. It was therefore not
surprising that the prevalence of the infection was
highest in April.
In conclusion, this study has provided insights on the
potential for induced malaria via blood transfusion. The
high prevalence of malaria parasites among blood
donors calls for a revisiting of the existing blood
donation policies in many health facilities in sub-
Saharan Africa to incorporate malaria screening among
donors. Outside of endemic areas, the policy of
screening the donors' history for known episodes of
clinical malaria or for tropical travel in the past 5 years
is generally sufficient (6,8,9). In other words, since it is
evident that malaria can be transmitted through blood
transfusion, there is a need for new donors-screening
assays to protect the integrity and purity of the blood
supplied. Blood should not be collected from donors12 McGill Journal of Medicine 2006
with suspected malaria. In malaria endemic area,
however, it is not feasible to screen all donors' blood for
Plasmodium species, or reject donors who had malaria
previously. In such cases, curative antimalarial drugs
followed by prophylactic drugs should be given to all
recipient of blood (10,33). This was demonstrated in a
cross-sectional study of 355 healthy blood donors in the
rainy season in Benin Republic, in which it was found
that 33.5% of donors harbored trophozoites and were
therefore capable of transmitting malaria via blood
donation (6). According to the report, there were 1,000
to 4,760 parasites per microliter of blood and there was
no relationship between the load of parasitized red
blood cells and clinical malaria, emphasizing the need
for the administration of antimalarial drug to recipients
of blood in malaria endemic regions.
It has been suggested that individuals suffering from
malaria or those within 3 months after treatment for
infection with malaria should not donate blood (34).
Furthermore, in spite of drug-resistant malaria, more
systematic care must be directed toward blood
screening (6). This is imperative because most
professional/commercial blood donors care little for
their health, may be carriers of blood borne diseases like
malaria, donate frequently in different places under
different names. An overhaul of methods of blood
procurement to include sub-group selection of donors
and improve funding of blood banking services is
therefore recommended. This will go a long way in
reducing the number of commercial blood donors and
may minimize the risk of transmission of Plasmodium
infection. Public participation and funding of safe
transmission in sub-Saharan African has been suggested
(35) and may reduce the chances of malaria-infection in
blood donors.
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Table 2.  Prevalence of malaria infection in blood donors in Abakaliki South-eastern Nigeria in relation to the blood group and various study
months
Parameter                          Number examined Number (%) infected 95% Confidence interval 
ABO blood group
O 281                                               115 (41.0)                                                        35.3-46.7
A                                                  25                                                  10 (40.0) 20.8-59.2
B                                                  19 8  (42.1) 19.6-64.6
Total 325 133  (40.9) 35.6-46.2
Month
February 35 13 (37.1) 21.1- 53.1
March 52                                                   21 (40.4) 27.1-53.7
April 105 45 (42.9) 33.4-52.4
May 98 40 (40.8) 31.1-50.5
June                                            35 14 (40.9) 24.7-57.1
Total                                          325 133 (40.9) 35.6-46.2
Table 1.  Guidelines to SFQ scores: SFQ score ranges indicative of likelihood of sexual dysfunction and normal function
Male Female Overall total                  95% CI
Age (yrs) NE NI(%) NE NI(%) NE                    NI(%) 
20-25 202            99  (49.0)                      2                  0   (0.0)                     204               99 (48.5)          41.6-55.4
26-30                                    83             26  (31.3)                      7                  3  (42.8)                      90               29  (32.2)         22.5-41.9 
31-35                                    20               3  (15.0)                      5                  2  (40.0)                      25                5   (20.0)         4.3-35.7
36-40                                     5 0   (0.0)                        1                  0   (0.0)                        6                 0  (0.0)                -
Total 310           128  (41.3)                     15                   5  (33.3)                   325             133   (40.9)         35.6-46.2
NE: Number examined
NI: Number infected Malaria 13 Vol. 9 No. 1
Medical Centre Abakaliki and Ebonyi State University
Teaching Hospital for logistic support.
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